|
[1]
|
Daviss, B. (2005) Growing Pains for Metabolomics—The Scientist Magazine of the Life Sciences. Scientist, 19, 25-28.
|
|
[2]
|
Beger, R.D., Dunn, W., Schmidt, M.A., Gross, S.S., Kirwan, J.A., Cascante, M., et al. (2016) Metabolomics Enables Precision Medicine: “A White Paper, Community Perspective”. Metabolomics, 12, Article No. 149. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Wen, S., Wang, C., Gong, M. and Zhou, L. (2018) An Overview of Energy and Metabolic Regulation. Science China Life Sciences, 62, 771-790. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Stryeck, S., Birner-Gruenberger, R. and Madl, T. (2017) Integrative Metabolomics as Emerging Tool to Study Autophagy Regulation. Microbial Cell, 4, 240-258. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Santos, P.C., Martínez-Laborde, C. And Díaz-Peña, R. (2015) Genomics, Proteomics and Metabolomics: Their Emerging Roles in the Discovery and Validation of Rheumatoid Arthritis Biomarkers. Clinical & Experimental Rheumatology, 33, 279.
|
|
[6]
|
Dunn, W. and Ellis, D.I. (2005) Metabolomics: Current Analytical Platforms and Methodologies. Trends in Analytical Chemistry, 24, 285-294.
|
|
[7]
|
Plumb, R.S., Stumpf, C.L., Granger, J.H., Castro-Perez, J., Haselden, J.N. and Dear, G.J. (2003) Use of Liquid Chromatography/Time-of-Flight Mass Spectrometry and Multivariate Statistical Analysis Shows Promise for the Detection of Drug Metabolites in Biological Fluids. Rapid Communications in Mass Spectrometry, 17, 2632-2638. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Lindon, J.C., Holmes, E. and Nicholson, J.K. (2003) Peer Reviewed: So What’s the Deal with Metabonomics? Analytical Chemistry, 75, 384 A-391 A. [Google Scholar] [CrossRef]
|
|
[9]
|
Hanlon, E.B., Manoharan, R., Koo, T., Shafer, K.E., Motz, J.T., Fitzmaurice, M., et al. (2000) Prospects Forin Vivoraman Spectroscopy. Physics in Medicine and Biology, 45, R1-R59. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Oliver, S. (1998) Systematic Functional Analysis of the Yeast Genome. Trends in Biotechnology, 16, 373-378. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Taylor, J., King, R.D., Altmann, T. and Fiehn, O. (2002) Application of Metabolomics to Plant Genotype Discrimination Using Statistics and Machine Learning. Bioinformatics, 18, S241-S248. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Pérez-Enciso, M. and Tenenhaus, M. (2003) Prediction of Clinical Outcome with Microarray Data: A Partial Least Squares Discriminant Analysis (PLS-DA) Approach. Human Genetics, 112, 581-592. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Wu, Y., Fu, Y., Rao, C., Li, W., Liang, Z., Zhou, C., et al. (2016) Metabolomic Analysis Reveals Metabolic Disturbances in the Prefrontal Cortex of the Lipopolysaccharide-Induced Mouse Model of Depression. Behavioural Brain Research, 308, 115-127. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Homayoun, S.B., Shrikant, I.B., Kazem, M., Hemmat, M. and Reza, M. (2011) Compared Application of the New OPLS-DA Statistical Model versus Partial Least Squares Regression to Manage Large Numbers of Variables in an Injury Case-Control Study. Scientific Research and Essays, 6, 4369-4377. [Google Scholar] [CrossRef]
|
|
[15]
|
Quintás, G., Portillo, N., García-Cañaveras, J.C., Castell, J.V., Ferrer, A. and Lahoz, A. (2011) Chemometric Approaches to Improve PLSDA Model Outcome for Predicting Human Non-Alcoholic Fatty Liver Disease Using UPLC-MS as a Metabolic Profiling Tool. Metabolomics, 8, 86-98. [Google Scholar] [CrossRef]
|
|
[16]
|
Witting, M., Hastings, J., Rodriguez, N., Joshi, C.J., Hattwell, J.P.N., Ebert, P.R., et al. (2018) Modeling Meets Metabolomics—The Wormjam Consensus Model as Basis for Metabolic Studies in the Model Organism Caenorhabditis Elegans. Frontiers in Molecular Biosciences, 5, Article No. 96. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Bin, W., Xueqing, H., Yanan, S., et al. (2016) A Metabolomic Research on “The Same TCM Syndrome” in the Postoperative Patients with Liver Cancer and Colorectal Cancer. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology.
|
|
[18]
|
Kaddurah-Daouk, R., Kristal, B.S. and Weinshilboum, R.M. (2008) Metabolomics: A Global Biochemical Approach to Drug Response and Disease. Annual Review of Pharmacology and Toxicology, 48, 653-683. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Cevallos-Cevallos, J.M., Reyes-De-Corcuera, J.I., Etxeberria, E., Danyluk, M.D. and Rodrick, G.E. (2009) Metabolomic Analysis in Food Science: A Review. Trends in Food Science & Technology, 20, 557-566. [Google Scholar] [CrossRef]
|
|
[20]
|
Beckles, D.M. and Roessner, U. (2012) Plant metabolomics. In: Plant Biotechnology and Agriculture, Elsevier, 67-81. [Google Scholar] [CrossRef]
|
|
[21]
|
Römisch-Margl, W., Prehn, C., Bogumil, R., Röhring, C., Suhre, K. and Adamski, J. (2011) Procedure for Tissue Sample Preparation and Metabolite Extraction for High-Throughput Targeted Metabolomics. Metabolomics, 8, 133-142. [Google Scholar] [CrossRef]
|
|
[22]
|
Planque, M., Igelmann, S., Ferreira Campos, A.M. and Fendt, S. (2023) Spatial Metabolomics Principles and Application to Cancer Research. Current Opinion in Chemical Biology, 76, Article 102362. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Callejón-Leblic, B., García-Barrera, T., Pereira-Vega, A. and Gómez-Ariza, J.L. (2019) Metabolomic Study of Serum, Urine and Bronchoalveolar Lavage Fluid Based on Gas Chromatography Mass Spectrometry to Delve into the Pathology of Lung Cancer. Journal of Pharmaceutical and Biomedical Analysis, 163, 122-129. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Woods, M.N., Wanke, C.A., Ling, P., Hendricks, K.M., Tang, A.M., Andersson, C.E., et al. (2009) Metabolic Syndrome and Serum Fatty Acid Patterns in Serum Phospholipids in Hypertriglyceridemic Persons with Human Immunodeficiency Virus. The American Journal of Clinical Nutrition, 89, 1180-1187. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Michelena, J., Alonso, C., Martínez-Arranz, I., Altamirano, J., Mayo, R., Sancho-Bru, P., et al. (2019) Metabolomics Discloses a New Non-Invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis. Annals of Hepatology, 18, 144-154. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Jinno, H., Murata, T., et al. (2016) Identification of Breast Cancer-Specific Signatures in Saliva Metabolites Using Capillary Electrophoresis Mass Spectrometry. Annals of Oncology, 25, Article No. 1.
|
|
[27]
|
Shao, C., Chen, C., Lin, J., Chen, C., Fu, S., Chen, Y., et al. (2017) Metabolite Marker Discovery for the Detection of Bladder Cancer by Comparative Metabolomics. Oncotarget, 8, 38802-38810. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
克拉热·阿合买提, 郑超, 马乐, 等. 结直肠癌前病变及肿瘤患者血清代谢物的差异分析[J]. 现代肿瘤医学, 2017, 25(9): 1421-1426.
|
|
[29]
|
Li, Y., Si, Y., Ma, Y. and Yin, H. (2023) Application and Prospect of Metabolomics in the Early Diagnosis of Osteoporosis: A Narrative Review. Bioanalysis, 15, 1369-1379. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Kant, S., Prabhu, A., Kesarwani, P., Kumar, P., Graham, S.F. and Chinnaiyan, P. (2018) Abstract 3474: Integrative Metabolomic and Genomic Analysis Identifies Fatty Acid Oxidation as a Metabolic Node in Glioblastoma. Cancer Research, 78, 3474-3474. [Google Scholar] [CrossRef]
|
|
[31]
|
Alosaimi, M.E., Alotaibi, B.S., Abduljabbar, M.H., Alnemari, R.M., Almalki, A.H. and Serag, A. (2024) Unveiling the Altered Metabolic Pathways Induced by Nivolumab in Non-Small Cell Lung Cancer via GC-MS Metabolomics Approach Coupled with Multivariate Analysis. Journal of Chromatography B, 1240, Article 124144. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Ferraro, G.B., Ali, A., Luengo, A., Kodack, D.P., Deik, A., Abbott, K.L., et al. (2021) Fatty Acid Synthesis Is Required for Breast Cancer Brain Metastasis. Nature Cancer, 2, 414-428. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Rhee, E.P. and Gerszten, R.E. (2012) Metabolomics and Cardiovascular Biomarker Discovery. Clinical Chemistry, 58, 139-147. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Kakisaka, K., Cazanave, S.C., Fingas, C.D., Guicciardi, M.E., Bronk, S.F., Werneburg, N.W., et al. (2012) Mechanisms of Lysophosphatidylcholine-Induced Hepatocyte Lipoapoptosis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 302, G77-G84. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Amier, R.P., Teunissen, P.F.A., Marques, K.M., Knaapen, P. and van Royen, N. (2013) Invasive Measurement of Coronary Microvascular Resistance in Patients with Acute Myocardial Infarction Treated by Primary PCI. Heart, 100, 13-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Ahmad, T., Kelly, J.P., McGarrah, R.W., Hellkamp, A.S., Fiuzat, M., Testani, J.M., et al. (2016) Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility with Mechanical Circulatory Support. Journal of the American College of Cardiology, 67, 291-299. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Israr, M.Z., Bernieh, D., Salzano, A., Cassambai, S., Yazaki, Y., Heaney, L.M., et al. (2021) Association of Gut-Related Metabolites with Outcome in Acute Heart Failure. American Heart Journal, 234, 71-80. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Dang, V.T., Huang, A. and Werstuck, G.H. (2018) Untargeted Metabolomics in the Discovery of Novel Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Diseases. Cardiovascular & Hematological Disorders-Drug Targets, 18, 166-175. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Hu, S. (2023) Report on Cardiovascular Health and Diseases in China 2021: An Updated Summary. Journal of Geriatric Cardiology, 20, 399-430. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Huang, C., Huang, Y., Lin, C. and Chen, J. (2021) Plasma Metabolomic Profiles Associated with Hypertension and Blood Pressure in Response to Thiazide Diuretics. Hypertension Research, 45, 464-473. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Furberg, A. and Thune, I. (2003) Metabolic Abnormalities (hypertension, Hyperglycemia and Overweight), Lifestyle (High Energy Intake and Physical Inactivity) and Endometrial Cancer Risk in a Norwegian Cohort. International Journal of Cancer, 104, 669-676. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Yu, Y., Jia, X., Wang, W., Jin, Y., Liu, W., Wang, D., et al. (2021) Floridean Starch and Floridoside Metabolic Pathways of Neoporphyra Haitanensis and Their Regulatory Mechanism under Continuous Darkness. Marine Drugs, 19, Article No. 664. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Gowda, G.N., Zhang, S., Gu, H., Asiago, V., Shanaiah, N. and Raftery, D. (2008) Metabolomics-Based Methods for Early Disease Diagnostics. Expert Review of Molecular Diagnostics, 8, 617-633. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Greenberg, N., Grassano, A., Thambisetty, M., Lovestone, S. and Legido-Quigley, C. (2009) A Proposed Metabolic Strategy for Monitoring Disease Progression in Alzheimer’s Disease. Electrophoresis, 30, 1235-1239. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Prajapati, A., Mehan, S. and Khan, Z. (2023) Correction to: The Role of SMO-Shh/GLI Signaling Activation in the Prevention of Neurological and Ageing Disorders. Biogerontology, 24, 829-829. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Ek, M., Söderdahl, T., Küppers-Munther, B., Edsbagge, J., Andersson, T.B., Björquist, P., et al. (2007) Expression of Drug Metabolizing Enzymes in Hepatocyte-Like Cells Derived from Human Embryonic Stem Cells. Biochemical Pharmacology, 74, 496-503. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
魏棒棒, 曹怿玮, 董春涛, 等. 代谢组学在不同分子亚型乳腺癌中的研究进展[J]. 中国现代应用药学, 2023, 40(5): 697-704.
|
|
[48]
|
Mussap, M. (2022) Special Issue on “The Application of Metabolomics in Clinical Practice: Challenges and Opportunities”. Metabolites, 12, Article No. 296. [Google Scholar] [CrossRef] [PubMed]
|